Chief Human Resources Officer · Tarsus Pharmaceuticals, Inc. (TARS)

MSW Dianne Whitfield

FY2021 is the first fiscal year CompBrief holds for MSW Dianne Whitfield as a named executive officer of Tarsus Pharmaceuticals; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$3,207,704

Salary $358,636Bonus $194,599

2nd of 3 named executive officers at Tarsus Pharmaceuticals by FY2021 total.

3 named officers on file for Tarsus Pharmaceuticals, FY2021

MSW Dianne Whitfield’s pay file — $29

  • 1 fiscal year of pay, line by line
  • TARS’s disclosed peer group of 16 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Tarsus Pharmaceuticals’s whole pay program stands against its peers

  • Tarsus Pharmaceuticals’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on TARS→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed May 2, 2022 (DEF 14A).

Free

Get MSW Dianne Whitfield’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

MSW Dianne Whitfield compensation by year

Tarsus Pharmaceuticals Summary Compensation Table · the one fiscal year held
In US dollars, as Tarsus Pharmaceuticals reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021
Salary$358,636
Bonus$194,599
Option awards$2,628,804
All other$25,665
Total$3,207,704

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Tarsus Pharmaceuticals, Inc. DEF 14A filed May 2, 2022, accession 0001193125-22-135208, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Tarsus Pharmaceuticals, Inc. filed document, accession 0001193125-22-135208. Every figure is read from that document and cited to the page and table it appears in. Filed May 2, 2022.

Tarsus Pharmaceuticals’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
Bobak AzamianPresident, Chief Executive Officer and Director$6,870,723
MSW Dianne Whitfield · this pageChief Human Resources Officer$3,207,704
Bryan WahlGeneral Counsel and Secretary$2,626,942

The full Tarsus Pharmaceuticals compensation record

free company brief

This page is one person within Tarsus Pharmaceuticals's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Tarsus Pharmaceuticals's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

MSW Dianne Whitfield's compensation dossier · One-time report. No refunds.